Shenzhen YHLO Biotech Co. Ltd. A (688575): Kapitalflussrechnung
| Preis (11.09.2026) | 52W Hoch | 52W Tief |
| 9,53 Renminbi Yuan | 16,962 Renminbi Yuan | 8,34 Renminbi Yuan |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 17,12 Renminbi Yuan | - | - | - | - | - |
| #Shares | Short [%] | Short Ratio |
| 571.388.300 | - | - |
Kennzahl in 1000 CNY | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 |
|---|---|---|---|---|---|---|---|---|---|
Umsatz | 1.809.107,8 | 2.011.620,28 | 2.053.101,446 | 3.980.756,763 | 1.177.896,226 | 999.007 | 877.357,946 | 728.644,764 | 530.060,629 |
Cashflow aus operativer Geschäftstätigkeit | 421.848,96 | 529.899,717 | -64.089,193 | 1.583.160,681 | 259.617,93 | 282.155,951 | 68.340,694 | 29.708,951 | 8.669,446 |
▸ Operative Cashflow Marge | 23,32% | 26,34% | -3,12% | 39,77% | 22,04% | 28,24% | 7,79% | 4,08% | 1,64% |
Investitionsausgaben (CapEx) | 359.240,491 | 593.310,1 | 662.711,017 | 565.374,781 | 372.661,353 | 189.392,93 | 128.093,281 | 186.392,078 | 83.019,265 |
Cashflow aus Investitionstätigkeit | - | -748.522,68 | -603.596,356 | -869.831,073 | -461.080,156 | -167.756,341 | -146.544,179 | -184.321,645 | -94.239,202 |
Cashflow aus Finanzierungstätigkeit | - | 180.709,916 | -59.638,05 | 13.471,484 | 447.545,809 | -8.762,545 | 142.439,002 | 133.550,85 | 50.045,835 |
Freier Cashflow | 62.608,469 | -63.410,383 | -726.800,21 | 1.017.785,9 | -113.043,423 | 92.763,021 | -59.752,587 | -156.683,127 | -74.349,819 |
▸ Freie Cashflow Marge | 3,46% | -3,15% | -35,4% | 25,57% | -9,6% | 9,29% | -6,81% | -21,5% | -14,03% |
Ausgeschüttete Dividenden | -141.578,199 | -169.034,015 | -255.658,095 | -162.000 | -10.901,23 | -21.840 | -1.000 | -10.458,377 | -14.283,182 |
Neuausgabe und Rückkäufe von Stammaktien | - | - | - | - | - | 4.758 | - | - | - |
Kennzahlen dieser Seite im Lexikon
Weitere Informationen findest du im Takani-Lexikon.